drugset
drugset / Trial / NCT01381341

To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib.

NCT01381341 ↗

Phase 1 Completed 13 enrolled Abbott
RandomizedCrossoverOpen-labelBasic science

Summary

A pharmacokinetic study to compare 2 clinical formulations of linifanib.

Timeline

Start
2011-05
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject ABT-869 Unknown — —

Indications

neoplasm